Table 1: Patient characteristics and DFO use.
Inpatient Use of DFO | DFO(n = 21) | No DFO(n = 187) |
---|---|---|
Serum ferritin, ng/mL |
8,873 (6,115-10,978) (n = 20) |
2,019 (747-5,226) (n = 136) |
Serum ferritin, n (%) < 1,000 ng/mL 1,000-2,499 ng/mL 2,500-4,000 ng/mL > 4,000 ng/mL |
1 (5) 0 2 (10) 17 (85) |
41 (30) 33 (24) 14 (10) 48 (36) |
Blood transfusions during study, mL/kg |
48 (19-54) |
9 (0-27) |
Patients on outpatient DFO Inpatient DFO dose, mg/kg Number of doses, median (range) |
(n = 6) 82 (55-90) 2 (1-5) |
(n = 7) n/a n/a |
Patients on outpatient DFS Inpatient DFO dose, mg/kg Number of doses, median (range) |
(n = 8) 17 (13-32) 1 (1-7) |
(n = 26) n/a n/a |
No outpatient chelation Inpatient DFO dose, mg/kg Number of doses, median (range) |
(n = 6) 39 (15-55) 1 (1-2) |
(n = 154) n/a n/a |
DFO: Deferoxamine; DFS: Deferasirox; Data presented is median (1st-3rd quartile) unless otherwise noted.